Engineers Gate Manager’s Repare Therapeutics RPTX Stock Holding History

Engineers Gate Manager’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,627	Closed	-$30.2K	–	2515
2025 Q4	$30.2K	Buy	11,627 +124	+1%	+$250	﹤0.01%	2010
2025 Q3	$20.2K	Hold	11,503	–	–	﹤0.01%	2100
2025 Q2	$16K	Buy	+11,503	New	+$15K	﹤0.01%	2098
2025 Q1	–	Sell	-18,122	Closed	-$23.7K	–	2512
2024 Q4	$23.7K	Buy	18,122 +6,733	+59%	+$20.1K	﹤0.01%	2152
2024 Q3	$39.2K	Sell	11,389 -3,374	-23%	-$11.1K	﹤0.01%	1995
2024 Q2	$48.7K	Buy	+14,763	New	+$52.6K	﹤0.01%	1817

Engineers Gate Manager's RPTX Position: Q1 2026 in Review

Engineers Gate Manager sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 11,627 shares — an estimated $30.2K sold.

Engineers Gate Manager first reported a position in RPTX in Q2 2024 and held it in 6 quarters. The position peaked at $48.7K in Q2 2024. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Engineers Gate Manager reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Engineers Gate Manager sold 11,627 Repare Therapeutics shares in Q1 2026, an estimated $30.2K.
Engineers Gate Manager first reported a position in Repare Therapeutics in Q2 2024 and held it in 6 quarters.
Engineers Gate Manager's Repare Therapeutics position peaked at $48.7K in Q2 2024.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.